JHM Schellens
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 11
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 4
- Neutropenia and Cancer Infections 4
- Drug Transport and Resistance Mechanisms 2
-
- Cancer therapeutics and mechanisms 8
- Co-authors
- Jaap Verweij (10 shared papers)G. Stoter (6 shared papers)M de Boer-Dennert (6 shared papers)A.S.T. Planting (4 shared papers)G.J. Creemers (3 shared papers)Jun Ma (2 shared papers)Hilde Rosing (2 shared papers)Mirna McDonald (1 shared paper)
- Journals
- British Journal of Cancer (10 papers)Clinical Pharmacology & Therapeutics (3 papers)Anti-Cancer Drugs (1 paper)Bioanalysis (1 paper)Journal of Oncology Pharmacy Practice (2 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
JHM Schellens
16 papers receiving 624 citations
Peers
Comparison fields: 5 of 61
- Oncology 359
- Toxicology 45
- Molecular Biology 380
- Pathology and Forensic Medicine 72
- Pharmacology 24
Countries citing papers authored by JHM Schellens
This map shows the geographic impact of JHM Schellens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JHM Schellens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JHM Schellens more than expected).
Fields of papers citing papers by JHM Schellens
This network shows the impact of papers produced by JHM Schellens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JHM Schellens. The network helps show where JHM Schellens may publish in the future.
Co-authors
The 25 scholars most cited alongside JHM Schellens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 124 | |
| 2 | 1996 | 124 | |
| 3 | 1996 | 122 | |
| 4 | 1998 | 53 | |
| 5 | 1996 | 39 | |
| 6 | 1995 | 29 | |
| 7 | 1994 | 29 | |
| 8 | 2000 | 25 | |
| 9 | 1997 | 24 | |
| 10 | 2007 | 23 | |
| 11 | 1998 | 18 | |
| 12 | 2012 | 12 | |
| 13 | 1996 | 10 | |
| 14 | 2008 | 9 | |
| 15 | 2009 | 3 | |
| 16 | 1999 | 3 | |
| 17 | 2008 | 0 |
About JHM Schellens
JHM Schellens is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Surgery and Pediatrics, Perinatology and Child Health, having authored 17 papers that have together received 647 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Lung Cancer Research Studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (4 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmaceutical studies and practices (2 papers) and Intraperitoneal and Appendiceal Malignancies (1 paper). The work is most often cited by research in Oncology (359 citations), Toxicology (45 citations), Molecular Biology (380 citations), Pathology and Forensic Medicine (72 citations) and Pharmacology (24 citations). JHM Schellens has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jaap Verweij, G. Stoter, M de Boer-Dennert, A.S.T. Planting, G.J. Creemers, Jun Ma, Hilde Rosing, Mirna McDonald, B. E. Davies and Jos H. Beijnen. Their work appears in journals such as British Journal of Cancer, Clinical Pharmacology & Therapeutics, Anti-Cancer Drugs, Bioanalysis and Journal of Oncology Pharmacy Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.